Literature DB >> 15800781

Functional interaction of CARD15/NOD2 and Crohn's disease-associated TNFalpha polymorphisms.

Ylva Linderson1, Francesca Bresso, Eva Buentke, Sven Pettersson, Mauro D'Amato.   

Abstract

BACKGROUND AND AIMS: Mutations/polymorphisms in the CARD15/NOD2 gene and in the promoter region of the TNFalpha gene are associated with susceptibility to and modulate the phenotype of Crohn's disease (CD). The molecular mechanisms for this genotype-phenotype correlation are yet to be elucidated. CARD15 is an intracellular receptor for bacterial muramyl dipeptide (MDP), and can elicit an inflammatory response via activation of the NF-kappaB pathway. MDP is also known to induce the expression of pro-inflammatory cytokines including TNFalpha, through a still poorly characterized signaling pathway. We sought to determine whether CARD15-mediated NF-kappaB activation can contribute to MDP-induced TNFalpha production and, consequently, if polymorphisms in both genes affect the control of such induction. METHODS/
RESULTS: Transfection and electrophoretic mobility shift assays (EMSA) experiments in HEK293 cells demonstrated that MDP exposure stimulates TNFalpha gene transcription, as a result of CARD15-induced NF-kappaB activation and binding to TNFalpha promoter. When the CD-associated CARD15 1007fs variant was analyzed, induction of TNFalpha promoter activity was found to be defective. Different combinations of CARD15 and TNFalpha promoter polymorphisms gave rise to distinct TNFalpha transcription levels.
CONCLUSIONS: CARD15 and TNFalpha promoter polymorphisms interact to exert a functional effect on MDP-induced TNFalpha production. This gene-gene interaction may contribute to interindividual variation in susceptibility to, and manifestation of, Crohn's disease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15800781     DOI: 10.1007/s00384-004-0732-z

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN: 0179-1958            Impact factor:   2.571


  41 in total

1.  Functional consequences of a polymorphism affecting NF-kappaB p50-p50 binding to the TNF promoter region.

Authors:  I A Udalova; A Richardson; A Denys; C Smith; H Ackerman; B Foxwell; D Kwiatkowski
Journal:  Mol Cell Biol       Date:  2000-12       Impact factor: 4.272

Review 2.  Inflammatory bowel disease.

Authors:  Daniel K Podolsky
Journal:  N Engl J Med       Date:  2002-08-08       Impact factor: 91.245

3.  Genetic influence on cytokine production in meningococcal disease.

Authors:  R G Westendorp; J A Langermans; T W Huizinga; C L Verweij; A Sturk
Journal:  Lancet       Date:  1997-06-28       Impact factor: 79.321

4.  Gene-environment interaction modulated by allelic heterogeneity in inflammatory diseases.

Authors:  Mathias Chamaillard; Dana Philpott; Stephen E Girardin; Habib Zouali; Suzanne Lesage; Fabrice Chareyre; The Hung Bui; Marco Giovannini; Ulrich Zaehringer; Virginie Penard-Lacronique; Philippe J Sansonetti; Jean-Pierre Hugot; Gilles Thomas
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-07       Impact factor: 11.205

5.  Impaired on/off regulation of TNF biosynthesis in mice lacking TNF AU-rich elements: implications for joint and gut-associated immunopathologies.

Authors:  D Kontoyiannis; M Pasparakis; T T Pizarro; F Cominelli; G Kollias
Journal:  Immunity       Date:  1999-03       Impact factor: 31.745

6.  Tumour necrosis factor (TNF) gene polymorphism in Crohn's disease (CD): influence on disease behaviour?

Authors:  E Louis; M Peeters; D Franchimont; L Seidel; F Fontaine; G Demolin; F Croes; P Dupont; L Davin; S Omri; P Rutgeerts; J Belaiche
Journal:  Clin Exp Immunol       Date:  2000-01       Impact factor: 4.330

7.  Identification of three new single nucleotide polymorphisms in the human tumor necrosis factor-alpha gene promoter.

Authors:  A M Uglialoro; D Turbay; P A Pesavento; J C Delgado; F E McKenzie; J G Gribben; D Hartl; E J Yunis; A E Goldfeld
Journal:  Tissue Antigens       Date:  1998-10

8.  NOD2 is a negative regulator of Toll-like receptor 2-mediated T helper type 1 responses.

Authors:  Tomohiro Watanabe; Atsushi Kitani; Peter J Murray; Warren Strober
Journal:  Nat Immunol       Date:  2004-06-27       Impact factor: 25.606

9.  NOD2 mediates anti-inflammatory signals induced by TLR2 ligands: implications for Crohn's disease.

Authors:  Mihai G Netea; Bart Jan Kullberg; Dirk J de Jong; Barbara Franke; Tom Sprong; Ton H J Naber; Joost P H Drenth; Jos W M Van der Meer
Journal:  Eur J Immunol       Date:  2004-07       Impact factor: 5.532

10.  Induction of Nod2 in myelomonocytic and intestinal epithelial cells via nuclear factor-kappa B activation.

Authors:  Olga Gutierrez; Carlos Pipaon; Naohiro Inohara; Ana Fontalba; Yasunori Ogura; Felipe Prosper; Gabriel Nunez; Jose L Fernandez-Luna
Journal:  J Biol Chem       Date:  2002-08-22       Impact factor: 5.157

View more
  3 in total

1.  Contribution of genetics to a new vision in the understanding of inflammatory bowel disease.

Authors:  A S Peña
Journal:  World J Gastroenterol       Date:  2006-08-14       Impact factor: 5.742

2.  The CTLA4 variants may interact with the IL23R- and NOD2-conferred risk in development of Crohn's disease.

Authors:  Ondrej Hradsky; Petra Dusatkova; Martin Lenicek; Jiri Bronsky; Jiri Nevoral; Libor Vitek; Milan Lukas; Ivana Zeniskova; Ondrej Cinek
Journal:  BMC Med Genet       Date:  2010-06-10       Impact factor: 2.103

Review 3.  Paediatric inflammatory bowel disease: a mechanistic approach to investigate exclusive enteral nutrition treatment.

Authors:  Lily Nahidi; Andrew S Day; Daniel A Lemberg; Steven T Leach
Journal:  Scientifica (Cairo)       Date:  2014-05-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.